Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - SHORT-TERM DEBT
Short-term Debt FATE - Fate Therapeutics, Inc.
6.18 M
LAST VALUE
-25.59%
2 YEAR CAGR
20.43%
5 YEAR CAGR
13.56%
10 YEAR CAGR